Literature DB >> 15086396

Differential expression of Toll-like receptor (TLR)-2 and TLR-4 on monocytes in human sepsis.

L Armstrong1, A R L Medford, K J Hunter, K M Uppington, A B Millar.   

Abstract

Toll-like receptors (TLRs) are a recently described family of immune receptors involved in the recognition of pathogen-associated molecular patterns (PAMPs). The central role of TLR-2 and TLR-4 in microbial responses suggests they may be implicated in the pathogenesis of human sepsis. We hypothesized that the incidence and outcome of sepsis would be influenced by the expression of TLR-2 and TLR-4 on monocytes. We have examined the expression of TLR-2 and TLR-4 mRNA and protein and their response to pro- and anti-inflammatory agents on monocytes from subjects in the intensive therapy unit (ITU) with and without Gram-negative, Gram-positive or polymicrobial sepsis. We compared these data to ITU and healthy control subjects. TLR-2 mRNA was significantly up-regulated on monocytes from subjects with both Gram-positive and Gram-negative sepsis. Similarly, we detected increased levels of TLR-2 protein on the surface of monocytes from sepsis subjects relative to ITU controls. TLR-4 mRNA was increased in Gram-positive subjects; however, there was no corresponding increase in TLR-4 protein. Although TLR-4 mRNA expression in healthy control monocytes could be modulated in vitro by culture with lipopolysaccharide or interleukin-10, this was not observed in monocytes obtained from sepsis and ITU control subjects, suggesting that septic and ITU control milieus may alter the immunoregulation of TLR-4 mRNA expression on monocytes. TLR-2 mRNA was not modulated in culture by any stimulus in any group. We suggest that expression and regulatory response of monocyte TLR-2, and to a lesser extent TLR-4 may be abnormal in human sepsis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15086396      PMCID: PMC1809013          DOI: 10.1111/j.1365-2249.2004.02433.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells.

Authors:  M Muzio; D Bosisio; N Polentarutti; G D'amico; A Stoppacciaro; R Mancinelli; C van't Veer; G Penton-Rol; L P Ruco; P Allavena; A Mantovani
Journal:  J Immunol       Date:  2000-06-01       Impact factor: 5.422

2.  The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens.

Authors:  D M Underhill; A Ozinsky; A M Hajjar; A Stevens; C B Wilson; M Bassetti; A Aderem
Journal:  Nature       Date:  1999-10-21       Impact factor: 49.962

3.  The internalization time course of a given lipopolysaccharide chemotype does not correspond to its activation kinetics in monocytes.

Authors:  A Lentschat; V T El-Samalouti; J Schletter; S Kusumoto; L Brade; E T Rietschel; J Gerdes; M Ernst; H Flad; A J Ulmer
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

Review 4.  The Toll/interleukin-1 receptor domain: a molecular switch for inflammation and host defence.

Authors:  L O'Neill
Journal:  Biochem Soc Trans       Date:  2000-10       Impact factor: 5.407

5.  MD-2 enables Toll-like receptor 2 (TLR2)-mediated responses to lipopolysaccharide and enhances TLR2-mediated responses to Gram-positive and Gram-negative bacteria and their cell wall components.

Authors:  R Dziarski; Q Wang; K Miyake; C J Kirschning; D Gupta
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

Review 6.  Structure and function of Toll-like receptor proteins.

Authors:  T K Means; D T Golenbock; M J Fenton
Journal:  Life Sci       Date:  2000-12-08       Impact factor: 5.037

7.  Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression.

Authors:  F Nomura; S Akashi; Y Sakao; S Sato; T Kawai; M Matsumoto; K Nakanishi; M Kimoto; K Miyake; K Takeda; S Akira
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

8.  Regulation of Toll-like receptors in human monocytes and dendritic cells.

Authors:  A Visintin; A Mazzoni; J H Spitzer; D H Wyllie; S K Dower; D M Segal
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

9.  Anti-inflammatory response of IL-4, IL-10 and TGF-beta in patients with systemic inflammatory response syndrome.

Authors:  D Torre; R Tambini; S Aristodemo; G Gavazzeni; A Goglio; C Cantamessa; A Pugliese; G Biondi
Journal:  Mediators Inflamm       Date:  2000       Impact factor: 4.711

Review 10.  The epidemiology of the systemic inflammatory response.

Authors:  C Brun-Buisson
Journal:  Intensive Care Med       Date:  2000       Impact factor: 17.440

View more
  44 in total

1.  Early life activation of toll-like receptor 4 reprograms neural anti-inflammatory pathways.

Authors:  Abdeslam Mouihate; Michael A Galic; Shaun L Ellis; Sarah J Spencer; Shigeki Tsutsui; Quentin J Pittman
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

2.  The impact of acute strenuous exercise on TLR2, TLR4 and HLA.DR expression on human blood monocytes induced by autologous serum.

Authors:  Stephen Booth; Geraint D Florida-James; Brian K McFarlin; Guillaume Spielmann; Daniel P O'Connor; Richard J Simpson
Journal:  Eur J Appl Physiol       Date:  2010-08-27       Impact factor: 3.078

3.  Preoperative Toll-like receptor expression in monocytes is associated with host immunological responses following gastrointestinal surgery.

Authors:  Satoshi Ono; Hironori Tsujimoto; Shu-ichi Hiraki; Manabu Kinoshita; Kazuo Hase
Journal:  World J Surg       Date:  2011-02       Impact factor: 3.352

Review 4.  Biomaterials for vaccine-based cancer immunotherapy.

Authors:  Rui Zhang; Margaret M Billingsley; Michael J Mitchell
Journal:  J Control Release       Date:  2018-10-09       Impact factor: 9.776

5.  Creating a "pro-survival" phenotype through epigenetic modulation.

Authors:  Yongqing Li; Baoling Liu; Xuesong Gu; Ashley R Kochanek; Eugene Y Fukudome; Zhengcai Liu; Ting Zhao; Wei Chong; Yili Zhao; Dainan Zhang; Towia A Libermann; Hasan B Alam
Journal:  Surgery       Date:  2012-09       Impact factor: 3.982

6.  Differences in Toll-like receptor expression and cytokine production after stimulation with heat-killed Gram-positive and Gram-negative bacteria.

Authors:  O Beran; R Potměšil; M Holub
Journal:  Folia Microbiol (Praha)       Date:  2011-06-15       Impact factor: 2.099

Review 7.  Regenerative stromal cell therapy in allogeneic hematopoietic stem cell transplantation: current impact and future directions.

Authors:  Jeffery J Auletta; Kenneth R Cooke; Luis A Solchaga; Robert J Deans; Wouter van't Hof
Journal:  Biol Blood Marrow Transplant       Date:  2009-12-16       Impact factor: 5.742

8.  Antibody complementarity-determining regions (CDRs): a bridge between adaptive and innate immunity.

Authors:  Elena Gabrielli; Eva Pericolini; Elio Cenci; Federica Ortelli; Walter Magliani; Tecla Ciociola; Francesco Bistoni; Stefania Conti; Anna Vecchiarelli; Luciano Polonelli
Journal:  PLoS One       Date:  2009-12-04       Impact factor: 3.240

9.  Upregulation of TLR2/4 expression in mononuclear cells in postoperative systemic inflammatory response syndrome after liver transplantation.

Authors:  Ziqing Hei; Xinjin Chi; Nan Cheng; Gangjian Luo; Shangrong Li
Journal:  Mediators Inflamm       Date:  2010-06-16       Impact factor: 4.711

10.  Major hepatectomy induces phenotypic changes in circulating dendritic cells and monocytes.

Authors:  Philip A Efron; Tadashi Matsumoto; Priscilla F McAuliffe; Philip Scumpia; Ricardo Ungaro; Shiro Fujita; Lyle L Moldawer; David Foley; Alan W Hemming
Journal:  J Clin Immunol       Date:  2009-04-22       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.